DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

Delcath Systems, Inc. (NASDAQ: DCTH)



company name or ticker

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Ye

Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open F

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma

3 Basic Checks To Value Cheap Net Net Stocks

Delcath Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program

Delcath to Offer Data Highlighting Melphalan/HDS Trial at SSO Annual Meeting

Top Performing Industries For February 19, 2015

Stocks Hitting 52-Week Lows

Morning Market Losers

Earnings Preview: Intuitive Surgical Q4 2014

See More Articles...